Abstract: One-Year Cost-Comparison Analysis of Absorb™ Everolimus Eluting Bioresorbable Vascular Scaffold and Xience™ Everolimus Eluting Stent: Based on Findings From Absorb II

 

Abstract: One-Year Cost-Comparison Analysis of Absorb™ Everolimus Eluting Bioresorbable Vascular Scaffold and Xience™ Everolimus Eluting Stent: Based on Findings From Absorb II

The objective of this study was to compare the one-year costs related to cardiac adverse events post-index procedure discharge of Absorb and Xience.